Case Study: Boehringer Ingelheim achieves compliant, efficient pharmaceutical document creation with Quark XML Author

Boehringer Ingelheim Relies on XML Solution from Quarkto Create and Manage Legally Compliant Pharmaceutical Documents

Boehringer Ingelheim, a top-20 global pharmaceutical company with about 47,400 employees, needed a more secure, consistent and cost‑effective way to create, manage and publish legally compliant test specifications and analytical methods while speeding time to market. The challenge was to support extensive regulatory requirements (pharmaceutical laws, EU directives and internal standards) and a large document base, yet allow flexible entry of structured data and free text without slowing processes.

They implemented Quark XML Author integrated with Glemser’s xmContent as part of the GSpecS 9 project, replacing the prior RDBMS and enabling 500 users to produce valid XML directly in Microsoft Word with minimal training. The solution has generated roughly 20,000 test specifications to date, stores content as reusable central text blocks, enforces regulatory formatting (via components like xmRender), improves compliance and reuse across publications, and offers translation integration to boost ROI.

Boehringer Ingelheim